1-[2-chloro-5-[9-(piperazin-1-ylmethyl)-3-azaspiro[5.5]undecane-3-carbonyl]phenyl]pyrimidine-2,4-dione
C26H34ClN5O3 — CID 174206811
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-chloro-5-[9-(piperazin-1-ylmethyl)-3-azaspiro[5.5]undecane-3-carbonyl]phenyl]pyrimidine-2,4-dione
1-[2-chloro-5-[9-(piperazin-1-ylmethyl)-3-azaspiro[5.5]undecane-3-carbonyl]phenyl]pyrimidine-2,4-dione (PubChem CID 174206811) has the molecular formula C26H34ClN5O3 and a molecular weight of 500.04 g/mol. Its IUPAC name is 1-[2-chloro-5-[9-(piperazin-1-ylmethyl)-3-azaspiro[5.5]undecane-3-carbonyl]phenyl]pyrimidine-2,4-dione.
Molecular Properties
| Compound Name | 1-[2-chloro-5-[9-(piperazin-1-ylmethyl)-3-azaspiro[5.5]undecane-3-carbonyl]phenyl]pyrimidine-2,4-dione |
|---|---|
| PubChem CID | 174206811 |
| Molecular Formula | C26H34ClN5O3 |
| Molecular Weight | 500.04 g/mol |
| Exact Mass | 499.24 |
| IUPAC Name | 1-[2-chloro-5-[9-(piperazin-1-ylmethyl)-3-azaspiro[5.5]undecane-3-carbonyl]phenyl]pyrimidine-2,4-dione |
| SMILES | O=C(c1ccc(Cl)c(-n2ccc(=O)[nH]c2=O)c1)N1CCC2(CCC(CN3CCNCC3)CC2)CC1 |
| InChI | InChI=1S/C26H34ClN5O3/c27-21-2-1-20(17-22(21)32-12-5-23(33)29-25(32)35)24(34)31-13-8-26(9-14-31)6-3-19(4-7-26)18-30-15-10-28-11-16-30/h1-2,5,12,17,19,28H,3-4,6-11,13-16,18H2,(H,29,33,35) |
| InChIKey | QAHRWXNVPLFEQL-UHFFFAOYSA-N |
| XLogP | 2.50 |
| TPSA | 90.44 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 500.04 |
| LogP ≤ 5 | 2.50 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174206811 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.